NXTC Stock Analysis: Buy, Sell, or Hold?
NXTC - NextCure, Inc. Common Stock
$10.85
0.43 (4.13%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
Get Alerted When NXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NXTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NXTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NXTC is currently trading at $10.85, which is considered oversold relative to its 30-day fair value range of $11.77 to $13.76.
Technical Outlook: Technically, NXTC is in a strong uptrend. Immediate support is located at $10.42, while resistance sits at $13.60. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.67 (+62.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NXTC is in a strong uptrend. Immediate support is located at $10.42, while resistance sits at $13.60. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.67 (+62.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$11.77 -
$13.76
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
Protect Your Profits
Holding NXTC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 62.8% below Wall St target ($17.67)
- CAUTION: Recommendation downgraded due to -9.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$11.77 -
$13.76
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$10.42
Resistance Level
$13.60
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.32
Wall Street Target
$17.67
(+62.8%)
Revenue Growth (YoY)
-100.0%
Last updated: January 31, 2026 9:37 PM ET
Data refreshes hourly during market hours. Next update: 10:37 PM
Data refreshes hourly during market hours. Next update: 10:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
Advanced NXTC Option Strategies
Professional options setups generated by AI based on today's NXTC price and gamma walls.
